{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T19:15:07Z","timestamp":1772997307828,"version":"3.50.1"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Pediatr Emer Care"],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>The study used an epidemiological and pharmacological description of child and adolescent psychiatric emergencies (CAPEs), during which psychotropic medications are frequently administered as off-label therapies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We retrospectively describe CAPE in 190 patients (mean age, 14.7 years) referring in the emergency department of a single tertiary center, from June 2016 to June 2018, focusing on off-label administration rate, most of all in emergency setting.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>An intrinsic fragility was observed in this population, where 28.4% of patients present a history of self-harm, 24.7% a concomitant neurodevelopmental disorder, and 17.3% a history of substance abuse. Psychomotor agitation was the most frequent referral reason, and it represents an unspecified clinical presentation of several conditions, while self-harm showed a stronger association with depressive disorders (55.2%).<\/jats:p>\n            <jats:p>Globally, 811 medications were administered both as baseline therapy (67.8% of off-label rate) and\/or in the emergency setting, where the off-label rate raised to 78.3%. Benzodiazepines had the highest rate of off-label use (98.2% as baseline therapy, 92.9% in acute context). Nevertheless, in 83.5% cases of acute administrations, a singular oral benzodiazepine (mostly lorazepam) guaranteed psychomotor agitation resolution, with a lower rate of adverse effects in contrast with atypical antipsychotics.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Off-label drug use in CAPEs is a recurrent clinical practice. An international agreement about off-label drugs is crucial to obtain standard long-term pharmacoepidemiological, safety, and efficacy data. Pharmacological pediatric trials and international guidelines are also required to regulate pharmacological treatments of CAPEs, most of all in emergency settings.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/pec.0000000000002693","type":"journal-article","created":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T14:00:58Z","timestamp":1654869658000},"page":"e1660-e1663","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Epidemiological and Psychopharmacological Study About Off-Label Treatment in Child and Adolescent Psychiatric Emergencies"],"prefix":"10.1097","volume":"38","author":[{"given":"Sara","family":"Minghetti","sequence":"first","affiliation":[{"name":"Child Neurology and Psychiatry Department, Children's Hospital A. Meyer, Florence"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Vannini","sequence":"additional","affiliation":[{"name":"Child Neurology and Psychiatry Department, Children's Hospital A. Meyer, Florence"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Casula","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences and Public Health, University of Cagliari, Cagliari"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Asprea","sequence":"additional","affiliation":[{"name":"Pharmacology Department, Children's Hospital A. Meyer, Florence, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Gori","sequence":"additional","affiliation":[{"name":"Child Neurology and Psychiatry Department, Children's Hospital A. Meyer, Florence"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Maria","family":"Calvani","sequence":"additional","affiliation":[{"name":"Pharmacology Department, Children's Hospital A. Meyer, Florence, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8920-9078","authenticated-orcid":false,"given":"Tiziana","family":"Pisano","sequence":"additional","affiliation":[{"name":"Child Neurology and Psychiatry Department, Children's Hospital A. Meyer, Florence"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,4,3]]},"reference":[{"key":"bib1-20250504","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.acap.2014.07.007","article-title":"Annual report on health care for children and youth in the United States: national estimates of cost, utilization and expenditures for children with mental health conditions","volume":"15","year":"2015","journal-title":"Acad Pediatr"},{"key":"bib2-20250504","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/acem.12282","article-title":"Trends in pediatric visits to the emergency department for psychiatric illnesses","volume":"21","year":"2014","journal-title":"Acad Emerg Med"},{"key":"bib3-20250504","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11920-016-0670-9","article-title":"Child psychiatric emergencies: updates on trends, clinical care, and practice challenges","volume":"18","year":"2016","journal-title":"Curr Psychiatry Rep"},{"key":"bib4-20250504","first-page":"1","article-title":"Mental health surveillance among children\u2014United States, 2005\u20132011","volume":"17","year":"2013","journal-title":"MMWR Suppl"},{"key":"bib5-20250504","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/S0140-6736(15)00390-6","article-title":"Addressing the burden of mental, neurological, and substance use disorders: key messages from Disease Control Priorities, 3rd edition","volume":"387","year":"2016","journal-title":"Lancet"},{"key":"bib6-20250504","year":"2008","journal-title":"The global burden of disease: 2004 update"},{"key":"bib7-20250504","doi-asserted-by":"crossref","first-page":"42","DOI":"10.12927\/hcq.2016.24481","article-title":"Early intervention in mood and anxiety disorders: the First Episode Mood and Anxiety Program (FEMAP)","volume":"18","year":"2016","journal-title":"Healthc Q"},{"key":"bib8-20250504","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/bmj.325.7367.749","article-title":"Association between psychological symptoms in adults and growth in early life: longitudinal follow up study","volume":"325","year":"2002","journal-title":"BMJ"},{"key":"bib9-20250504","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1192\/bjp.179.3.203","article-title":"Adolescents' self-reported problems as predictors of psychopathology in adulthood: 10-year follow-up study","volume":"179","year":"2001","journal-title":"Br J Psychiatry"},{"key":"bib10-20250504","first-page":"17","article-title":"Comorbidity of DSM-III-R major depressive disorder in the general population: results from the US National Comorbidity Survey","year":"1996","journal-title":"Br J Psychiatry"},{"key":"bib11-20250504","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1001\/archpsyc.60.7.709","article-title":"Prior juvenile diagnoses in adults with mental disorder","volume":"60","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"bib12-20250504","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.amepre.2015.10.007","article-title":"Global status report on violence prevention 2014","volume":"50","year":"2016","journal-title":"Am J Prev Med"},{"key":"bib13-20250504","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/PEC.0000000000000112","article-title":"Pharmacologic management of the agitated child","volume":"30","year":"2014","journal-title":"Pediatr Emerg Care"},{"key":"bib14-20250504","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.pneurobio.2016.05.003","article-title":"Challenges in developing drugs for pediatric CNS disorders: a focus on psychopharmacology","volume":"152","year":"2017","journal-title":"Prog Neurobiol"},{"key":"bib15-20250504","doi-asserted-by":"crossref","first-page":"409","DOI":"10.5811\/westjem.2019.1.41344","article-title":"Best practices for evaluation and treatment of agitated children and adolescents (Beta) in the emergency department: consensus statement of the American Association for Emergency psychiatry","volume":"20","year":"2019","journal-title":"West J Emerg Med"},{"key":"bib16-20250504","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1177\/0269881116636107","article-title":"BAP position statement: off-label prescribing of psychotropic medication to children and adolescents","volume":"30","year":"2016","journal-title":"J Psychopharmacol"},{"key":"bib17-20250504","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1001\/jamapsychiatry.2018.1080","article-title":"The urgent need for optimal monitoring of metabolic adverse effects in children and youngsters who take on-label or off-label antipsychotic medication","volume":"75","year":"2018","journal-title":"JAMA Psychiat"},{"key":"bib18-20250504","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s00228-019-02641-0","article-title":"The evidence-based choice for antipsychotics in children and adolescents should be guaranteed","volume":"75","year":"2019","journal-title":"Eur J Clin Pharmacol"},{"key":"bib19-20250504","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.chc.2018.02.002","article-title":"Crisis in the emergency department: the evaluation and management of acute agitation in children and adolescents","volume":"27","year":"2018","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"key":"bib20-20250504","first-page":"455","article-title":"Pharmacologic management of agitation and aggression in a pediatric emergency department\u2014a retrospective cohort study","volume":"23","year":"2018","journal-title":"J Pediatr Pharmacol Ther"},{"key":"bib21-20250504","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.pcl.2013.06.006","article-title":"Pediatric mental health emergencies and special health care needs","volume":"60","year":"2013","journal-title":"Pediatr Clin North Am"},{"key":"bib22-20250504","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jemermed.2017.12.049","article-title":"Approach to the agitated emergency department patient","volume":"54","year":"2018","journal-title":"J Emerg Med"},{"key":"bib23-20250504","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1177\/070674371506000203","article-title":"The pharmacological management of oppositional behaviour, conduct problems, and aggression in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, and conduct disorder: a systematic review and meta-analysis. Part 2: antipsychotics and traditional mood stabilizers","volume":"60","year":"2015","journal-title":"Can J Psychiatry"},{"key":"bib25-20250504","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4103\/jrpp.JRPP_18_42","article-title":"Off-label prescribing of antipsychotics in a Danish child and adolescent","volume":"7","year":"2018","journal-title":"J Res Pharm Pract"},{"key":"bib26-20250504","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1089\/cap.2016.0202","article-title":"Extent and risks of antipsychotic off-label use in children and adolescents in Germany between 2004 and 2011","volume":"27","year":"2017","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"bib27-20250504","first-page":"1137","article-title":"Drug metabolism for the paediatrician","volume":"99","year":"2014","journal-title":"Arch Dis Child Educ Pract Ed"},{"key":"bib28-20250504","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1002\/da.22643","article-title":"The efficacy of benzodiazepines as acute anxiolytics in children: a meta-analysis","volume":"34","year":"2017","journal-title":"Depress Anxiety"},{"key":"bib29-20250504","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.annemergmed.2019.05.020","article-title":"Intranasal lorazepam for treatment of severe agitation in a pediatric behavioral health patient in the emergency department","volume":"75","year":"2020","journal-title":"Ann Emerg Med"},{"key":"bib30-20250504","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jemermed.2017.10.011","article-title":"Evidence-based review of pharmacotherapy for acute agitation. Part 1: onset of efficacy","volume":"54","year":"2018","journal-title":"J Emerg Med"},{"key":"bib31-20250504","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.biopsych.2014.01.006","article-title":"A neurodevelopmental perspective on the research domain criteria (RDoC) framework","volume":"76","year":"2014","journal-title":"Biol Psychiatry"},{"key":"bib32-20250504","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1002\/da.22944","article-title":"Mood and suicidality outcomes 3\u201311 years following pediatric anxiety disorder treatment","volume":"36","year":"2019","journal-title":"Depress Anxiety"},{"key":"bib33-20250504","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1097\/PEC.0b013e3182a393e7","article-title":"Emergency psychiatric care for children and adolescents: a literature review","volume":"29","year":"2013","journal-title":"Pediatr Emerg Care"},{"key":"bib34-20250504","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1177\/1367493518787925","article-title":"Assessment tools of immediate risk of self-harm and suicide in children and young people: a scoping review","volume":"23","year":"2019","journal-title":"J Child Health Care"}],"container-title":["Pediatric Emergency Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PEC.0000000000002693","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T18:04:27Z","timestamp":1746381867000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PEC.0000000000002693"}},"subtitle":["A Tertiary\/Single Center Experience"],"short-title":[],"issued":{"date-parts":[[2022,4,3]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/pec.0000000000002693","relation":{},"ISSN":["1535-1815","0749-5161"],"issn-type":[{"value":"1535-1815","type":"electronic"},{"value":"0749-5161","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4,3]]}}}